Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion Announces EU Grant Award For The Covid-19 Vaccine Development Programme

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    06/03/2020 12:38
    March 6 (Reuters) - ExpreS2ion Biotech Holding AB  EXPRS2.ST :
    * EXPRES2ION ANNOUNCES EU GRANT AWARD FOR THE COVID-19 VACCINE DEVELOPMENT PROGRAMME
    * EXPRES2ION BIOTECH HOLDING AB - AWARD FUNDING AMOUNTS TO 2,7 MEUR (28MSEK), OF WHICH
EXPRES(2)ION DIRECTLY IS FUNDED WITH 0.88 MEUR (9.3 MSEK).
    * EXPRES2ION BIOTECH HOLDING AB -  EXPRES(2)ION BIOTECHNOLOGIES APS ANNOUNCES THAT
CONSORTIUM HAS
BEEN AWARDED AN EU HORIZON 2020 GRANT FOR COVID-19 (SARS-COV-2) CORONAVIRUS VACCINE DEVELOPMENT
PROGRAMME

Source text for Eikon:  ID:nWkr1zgdjy 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news